<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-LYGZENZ0</identifier><date>2013</date><creator>Vukan, Valerija</creator><relation>documents/doc/L/URN_NBN_SI_doc-LYGZENZ0_001.htm</relation><relation>documents/doc/L/URN_NBN_SI_doc-LYGZENZ0_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LYGZENZ0_001.txt</relation><format format_type="issue">1</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 3-10</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">26964775</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LYGZENZ0</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antagonisti angiotenzina</subject><subject language_type_id="slv">arterijska hipertenzija</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">sartani</subject><subject language_type_id="slv">zdravila</subject><title>Arterial hypertension</title><title>Arterijska hipertenzija</title><title>comparison of ACE inhibitors and sartans</title><title>primerjava zaviralcev ACE in sartanov</title></Record>